BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 32657028)

  • 1. Autocrine INSL5 promotes tumor progression and glycolysis via activation of STAT5 signaling.
    Li SB; Liu YY; Yuan L; Ji MF; Zhang A; Li HY; Tang LQ; Fang SG; Zhang H; Xing S; Li MZ; Zhong Q; Lin SJ; Liu WL; Huang P; Zeng YX; Zheng YM; Ling ZQ; Sui JH; Zeng MS
    EMBO Mol Med; 2020 Sep; 12(9):e12050. PubMed ID: 32657028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CircZNF609 promotes cell proliferation, migration, invasion, and glycolysis in nasopharyngeal carcinoma through regulating HRAS via miR-338-3p.
    Liu Z; Liu F; Wang F; Yang X; Guo W
    Mol Cell Biochem; 2021 Jan; 476(1):175-186. PubMed ID: 32970285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JMJD2A promotes the Warburg effect and nasopharyngeal carcinoma progression by transactivating LDHA expression.
    Su Y; Yu QH; Wang XY; Yu LP; Wang ZF; Cao YC; Li JD
    BMC Cancer; 2017 Jul; 17(1):477. PubMed ID: 28693517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AR-induced long non-coding RNA LINC01503 facilitates proliferation and metastasis via the SFPQ-FOSL1 axis in nasopharyngeal carcinoma.
    He SW; Xu C; Li YQ; Li YQ; Zhao Y; Zhang PP; Lei Y; Liang YL; Li JY; Li Q; Chen Y; Huang SY; Ma J; Liu N
    Oncogene; 2020 Aug; 39(34):5616-5632. PubMed ID: 32661324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactate dehydrogenase A promotes nasopharyngeal carcinoma progression through the TAK1/NF-κB Axis.
    Li Y; Chen L; Zheng Q; Liu G; Wang M; Wei S; Chen T
    Mol Biol Rep; 2024 Jan; 51(1):152. PubMed ID: 38236332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
    Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
    Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
    [No Abstract]   [Full Text] [Related]  

  • 7. Methylation-associated silencing of miR-9-1 promotes nasopharyngeal carcinoma progression and glycolysis via HK2.
    Xu QL; Luo Z; Zhang B; Qin GJ; Zhang RY; Kong XY; Tang HY; Jiang W
    Cancer Sci; 2021 Oct; 112(10):4127-4138. PubMed ID: 34382305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reducing NETO2 expression prevents human nasopharyngeal carcinoma (NPC) progression by suppressing metastasis and inducing apoptosis.
    He AR; Zhu Q; Gao S
    Biochem Biophys Res Commun; 2019 May; 513(2):494-501. PubMed ID: 30975469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CircHIPK3 promotes proliferation and invasion in nasopharyngeal carcinoma by abrogating miR-4288-induced ELF3 inhibition.
    Ke Z; Xie F; Zheng C; Chen D
    J Cell Physiol; 2019 Feb; 234(2):1699-1706. PubMed ID: 30070690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chibby suppresses aerobic glycolysis and proliferation of nasopharyngeal carcinoma via the Wnt/β-catenin-Lin28/let7-PDK1 cascade.
    Cai CF; Ye GD; Shen DY; Zhang W; Chen ML; Chen XX; Han DX; Mi YJ; Luo QC; Cai WY; Yang SY
    J Exp Clin Cancer Res; 2018 May; 37(1):104. PubMed ID: 29764469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homeodomain protein DLX4 facilitates nasopharyngeal carcinoma progression via up-regulation of YB-1.
    Ling Z; Long X; Li J; Feng M
    Genes Cells; 2020 Jul; 25(7):466-474. PubMed ID: 32281175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LPLUNC1 reduces glycolysis in nasopharyngeal carcinoma cells through the PHB1-p53/c-Myc axis.
    Oyang L; Ouyang L; Yang L; Lin J; Xia L; Tan S; Wu N; Han Y; Yang Y; Li J; Chen X; Tang Y; Su M; Luo X; Li J; Xiong W; Zeng Z; Liao Q; Zhou Y
    Cancer Sci; 2023 Mar; 114(3):870-884. PubMed ID: 36382614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXC2 positively regulates YAP signaling and promotes the glycolysis of nasopharyngeal carcinoma.
    Song L; Tang H; Liao W; Luo X; Li Y; Chen T; Zhang X
    Exp Cell Res; 2017 Aug; 357(1):17-24. PubMed ID: 28433696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Macrophage Migration Inhibitory Factor and CCL3 as Potential Biomarkers for Distinguishing Patients with Nasopharyngeal Carcinoma from High-Risk Individuals Who Have Positive Epstein-Barr Virus Capsid Antigen-Specific IgA.
    Xue N; Lin JH; Xing S; Liu D; Li SB; Lai YZ; Wang XP; Mao MJ; Zhong Q; Zeng MS; Liu WL
    Cancer Res Treat; 2019 Jan; 51(1):378-390. PubMed ID: 29807404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Epstein-Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy.
    Xiao L; Hu ZY; Dong X; Tan Z; Li W; Tang M; Chen L; Yang L; Tao Y; Jiang Y; Li J; Yi B; Li B; Fan S; You S; Deng X; Hu F; Feng L; Bode AM; Dong Z; Sun LQ; Cao Y
    Oncogene; 2014 Sep; 33(37):4568-78. PubMed ID: 24662831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNA-342-3p targets FOXQ1 to suppress the aggressive phenotype of nasopharyngeal carcinoma cells.
    Cui Z; Zhao Y
    BMC Cancer; 2019 Jan; 19(1):104. PubMed ID: 30678643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA NPCCAT1 promotes nasopharyngeal carcinoma progression via upregulating YY1.
    Su H; Liu L; Zhang Y; Wang J; Zhao Y
    Biochimie; 2019 Feb; 157():184-194. PubMed ID: 30481541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXM1 regulates glycolysis in nasopharyngeal carcinoma cells through PDK1.
    Yang Q; Wu F; Zhang Y; Wang R
    J Cell Mol Med; 2022 Jul; 26(13):3783-3796. PubMed ID: 35656815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA TGFBR2 acts as a ceRNA to suppress nasopharyngeal carcinoma progression by sponging miR-107.
    Li W; Lu H; Wang H; Ning X; Liu Q; Zhang H; Liu Z; Wang J; Zhao W; Gu Y; Li H; Sun X; Hu L; Wang D
    Cancer Lett; 2021 Feb; 499():301-313. PubMed ID: 33160003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MircoRNA-629 promotes proliferation, invasion and migration of nasopharyngeal carcinoma through targeting PDCD4.
    Zheng YQ; Bai YF; Yang S; Cui YR; Wang YP; Hu WL
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):207-216. PubMed ID: 30657562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.